-
Je něco špatně v tomto záznamu ?
7H-dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells
Vondrácek J, Svihálková-Sindlerová L, Pencíková K, Krcmár P, Andrysík Z, Chramostová K, Marvanová S, Valovicová Z, Kozubík A, Gábelová A, Machala M.
Jazyk angličtina Země Nizozemsko
- MeSH
- aromatické hydroxylasy genetika MeSH
- buněčná smrt účinky léků MeSH
- cytochrom P-450 CYP1A1 genetika MeSH
- cytochrom P-450 CYP1A2 genetika MeSH
- DNA primery MeSH
- epitelové buňky patologie účinky léků MeSH
- financování organizované MeSH
- játra cytologie účinky léků MeSH
- karbazoly toxicita MeSH
- karcinogeny toxicita MeSH
- krysa rodu rattus MeSH
- metylace MeSH
- molekulární struktura MeSH
- mutageny MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- potkani inbrední F344 MeSH
- sekvence nukleotidů MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
Immature liver progenitor cells have been suggested to be an important target of hepatotoxins and hepatocarcinogens. The goal of the present study was to assess the impact of 7H-dibenzo[c,g]carbazole (DBC) and its tissue-specific carcinogenic N-methyl (N-MeDBC) and 5,9-dimethyl (DiMeDBC) derivatives on rat liver epithelial WB-F344 cells, in vitro model of liver progenitor cells. We investigated the cellular events associated with both tumor initiation and promotion, such as activation of aryl hydrocarbon receptor (AhR), changes in expression of enzymes involved in metabolic activation of DBC and its derivatives, effects on cell cycle, cell proliferation/apoptosis and inhibition of gap junctional intercellular communication (GJIC). N-MeDBC, a tissue-specific sarcomagen, was only a weak inhibitor of GJIC or inducer of AhR-mediated activity, and it did not affect either cell proliferation or apoptosis. DBC was efficient GJIC inhibitor, while DiMeDBC manifested the strongest AhR inducing activity. Accordingly, DiMeDBC was also the most potent inducer of cytochrome P450 1A1 (CYP1A1) and CYP1A2 expression among the three compounds tested. Both DBC and DiMeDBC induced expression of CYP1B1 and aldo-keto reductase 1C9 (AKR1C9). N-MeDBC failed to significantly upregulate CYP1A1/2 and it only moderately increased CYP1B1 or AKR1C9. Only the potent liver carcinogens, DBC and DiMeDBC, caused a significant increase of p53 phosphorylation at Ser15, an increased accumulation of cells in S-phase and apoptosis at micromolar concentrations. In addition, DiMeDBC was found to stimulate cell proliferation of contact-inhibited WB-F344 cells at 1 microM concentration, which is a mode of action that might further contribute to its hepatocarcinogenicity. The present data seem to suggest that the AhR activation, induction of enzymes involved in metabolic activation, inhibition of GJIC or stimulation of cell proliferation might all contribute to the hepatocarcinogenic effects of DBC and DiMeDBC.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522884
- 003
- CZ-PrNML
- 005
- 20111210134555.0
- 008
- 090511s2006 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vondráček, Jan, $d 1970- $7 xx0137878
- 245 10
- $a 7H-dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells / $c Vondrácek J, Svihálková-Sindlerová L, Pencíková K, Krcmár P, Andrysík Z, Chramostová K, Marvanová S, Valovicová Z, Kozubík A, Gábelová A, Machala M.
- 314 __
- $a Laboratory of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Královopolská 135, 612 65 Brno, Czech Republic
- 520 9_
- $a Immature liver progenitor cells have been suggested to be an important target of hepatotoxins and hepatocarcinogens. The goal of the present study was to assess the impact of 7H-dibenzo[c,g]carbazole (DBC) and its tissue-specific carcinogenic N-methyl (N-MeDBC) and 5,9-dimethyl (DiMeDBC) derivatives on rat liver epithelial WB-F344 cells, in vitro model of liver progenitor cells. We investigated the cellular events associated with both tumor initiation and promotion, such as activation of aryl hydrocarbon receptor (AhR), changes in expression of enzymes involved in metabolic activation of DBC and its derivatives, effects on cell cycle, cell proliferation/apoptosis and inhibition of gap junctional intercellular communication (GJIC). N-MeDBC, a tissue-specific sarcomagen, was only a weak inhibitor of GJIC or inducer of AhR-mediated activity, and it did not affect either cell proliferation or apoptosis. DBC was efficient GJIC inhibitor, while DiMeDBC manifested the strongest AhR inducing activity. Accordingly, DiMeDBC was also the most potent inducer of cytochrome P450 1A1 (CYP1A1) and CYP1A2 expression among the three compounds tested. Both DBC and DiMeDBC induced expression of CYP1B1 and aldo-keto reductase 1C9 (AKR1C9). N-MeDBC failed to significantly upregulate CYP1A1/2 and it only moderately increased CYP1B1 or AKR1C9. Only the potent liver carcinogens, DBC and DiMeDBC, caused a significant increase of p53 phosphorylation at Ser15, an increased accumulation of cells in S-phase and apoptosis at micromolar concentrations. In addition, DiMeDBC was found to stimulate cell proliferation of contact-inhibited WB-F344 cells at 1 microM concentration, which is a mode of action that might further contribute to its hepatocarcinogenicity. The present data seem to suggest that the AhR activation, induction of enzymes involved in metabolic activation, inhibition of GJIC or stimulation of cell proliferation might all contribute to the hepatocarcinogenic effects of DBC and DiMeDBC.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aromatické hydroxylasy $x genetika $7 D001189
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a karbazoly $x toxicita $7 D002227
- 650 _2
- $a karcinogeny $x toxicita $7 D002273
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a cytochrom P-450 CYP1A1 $x genetika $7 D019363
- 650 _2
- $a cytochrom P-450 CYP1A2 $x genetika $7 D019388
- 650 _2
- $a DNA primery $7 D017931
- 650 _2
- $a epitelové buňky $x patologie $x účinky léků $7 D004847
- 650 _2
- $a játra $x cytologie $x účinky léků $7 D008099
- 650 _2
- $a metylace $7 D008745
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a mutageny $7 D009153
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední F344 $7 D011916
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 700 1_
- $a Švihálková Šindlerová, Lenka $7 xx0121174
- 700 1_
- $a Pěnčíková, Kateřina $7 xx0102049
- 700 1_
- $a Krčmář, Pavel $7 xx0137879
- 700 1_
- $a Andrysík, Zdeněk $7 xx0072995
- 700 1_
- $a Chramostová, Kateřina $7 xx0121880
- 700 1_
- $a Marvanová, Soňa. $7 _AN035139
- 700 1_
- $a Valovičová, Zuzana $7 xx0129041
- 700 1_
- $a Kozubík, Alois, $d 1958- $7 mzk2004237023
- 700 1_
- $a Gábelová, Alena $7 xx0118885
- 700 1_
- $a Machala, Miroslav $7 xx0094277
- 773 0_
- $w MED00003430 $t Mutation research. [All sections] $g Roč. 596, č. 1-2 (2006), s. 43-56 $x 0027-5107
- 910 __
- $a ABA008 $b B 1575 $y 9
- 990 __
- $a 20090506084234 $b ABA008
- 991 __
- $a 20111031115319 $b ABA008
- 999 __
- $a ok $b bmc $g 650974 $s 504141
- BAS __
- $a 3
- BMC __
- $a 2006 $b 596 $c 1-2 $d 43-56 $i 0027-5107 $m Mutation research $x MED00003430
- LZP __
- $a 2009-B2/vtme